UPDATED RESULTS OF A PHASE 2 STUDY FROM GELTAMO INVESTIGATING THE COMBINATION OF IBRUTINIB WITH R‐GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (17th June 2021)

• Record Type: Journal Article
• Authors: Búa, B. Rey; Jiménez‐Ubieto, A.; Blanco, J. J. Sánchez; Abrisqueta, P.; Gutiérrez, A.; Ramírez‐Páyer, Án.; Giné, E.; Etxetxipia, I. Zeberio; Terol, M. José; Cruz, F. de la; Andreu, R.; Ramírez, M.; Fuente, A. de la; Viguria, M.; Peñarrubia, M.; Grande, C.; Montes‐Moreno, S.; Barrigón, M. D. Caballero; García‐Sancho, A. Martín
• Is Part Of: Hematological oncology. Volume 39(2021)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.94_2880
• Languages: English
• ISSNs: 0278-0232